# Alcon to acquire Belkin Vision for up to $335M

Alcon, a Swiss-American ophthalmology firm, has agreed to acquire Israeli glaucoma treatment company Belkin Vision for a total potential sum of $335 million, including an initial payment of $60 million and additional milestone payments.

- Type: Acquisition
- Announced: 2024-05-06
- Where: Israel
- Value: $335.0M
- Status: announced
- Products: glaucoma laser treatment device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alcon Group](https://endata.com/companies/16712.md) (acquirer)
- [Belkin Vision](https://endata.com/companies/77234.md) (target)

## Sources

- [jewisheconomist.com](https://www.jewisheconomist.com/alcons-acquisition-of-belkin-vision-a-game-changer-in-glaucoma-treatment/), 2024-05-06: "Alcon, the Swiss-American ophthalmology firm, is set to acquire Israeli glaucoma treatment company Belkin Vision for a total potential sum of $335 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.